A new clinical trial is enrolling afib patients who, because of your doctor’s decision or your preference, are not currently taking an anticoagulant (blood thinner) to reduce the risk of clots and stroke. The LILAC – TIMI 76 trial will evaluate a monthly medication from a new class of anticoagulants. This clinical trial is recruiting …
Read More
People living with afib often ask if it is safe and effective to take blood thinners as “pill in the pocket” medications. We don’t have the answer yet. However, a new study seeks to answer that question. In the survey that many of you responded to in 2021, you expressed an interest in participating in …
Read More
This month, at the American Heart Association Scientific Sessions held in Philadelphia, several important Afib Late-Breaking Clinical Trials were presented that I want to share with you. These include AZALEA, ARTESiA, and NOAH-AFNET 6. We have posted news stories about them, which you can access here: Afib News from the American Heart Association Scientific Sessions …
Read More
Medicare will negotiate the prices of two afib drugs and is holding Virtual Listening Sessions. They seek to understand the patient's experience with these medications and their alternatives. StopAfib.org has applied to speak on behalf of the afib patient community. We are launching a survey to inform our comments. We would like to understand your …
Read More
If you’re new to our community, please check out these tools when deciding whether to take blood thinners. Even if you have used them previously, things may have changed about your afib, so it may be worth looking at them again. These tools come from the ENHANCE-AF (Engaging Patients to Help Achieve Increased Patient Choice …
Read More
Patient-Relevant Bleeding Events Among Patients Taking Anticoagulant Medication was recently presented at the International Society on Thrombosis and Haemostasis’ (ISTH) annual meeting in Montreal. Anthos Therapeutics, in collaboration with StopAfib.org and the National Blood Clot Alliance (NBCA), presented new data from a survey of afib and VTE patients about the impact of so-called “minor bleeding” on …
Read More
Some new tools are available for your use in deciding whether to take blood thinners. These tools come from the ENHANCE-AF (Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AF Stroke Prevention) Trial that our founder helped with. The American Heart Association funded the trial, the principal investigators were at Stanford University, …
Read More
Dallas, December 13, 2021—What can you do with some 2022 insurance plans no longer covering Eliquis, Pradaxa, and Savaysa? What is the problem? We have become aware that CVS Caremark, the company that manages the prescription medications for many US health insurance plans, has decided to drop coverage for Eliquis, Pradaxa, and Savaysa from many …
Read More
Update: This survey is now closed. We would appreciate your help with a survey to help a researcher at Northwestern University. He is working on developing a study into the use of blood thinners on an “as needed” basis compared to continuous use of blood thinners. If funded, the study would use a smart watch …
Read More
Since its completion, the CABANA Trial has gotten a lot of attention. You may have heard or read about it and wondered what its findings may mean for your own situation and treatment. Sometimes, sorting through all the information you’re hearing can feel a bit overwhelming—especially when a lot of it is just opinion or …
Read More